thereby producing in the affected chimpanzees a clinical picture and pathological findings similar in nature to those in the human subject. In the other form, the inoculation of material from cases of Creutzfeldt-Jakob disease has not produced the syndrome in chimpanzees.
The age and onset of the signs and symptoms in this patient are consistent with a diagnosis of Type lb Creutzfeldt-Jakob disease. The EEG abnormality and the myoclonic jerks present fifteen years previously are extremely unusual in that so protracted a course for this complaint has probably not been recorded before. REFERENCE Roos R, Gajdusek D C & Gibbs C J (1973) Brain 96, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Dr P Rudge said that it would be interesting to inoculate a chimpanzee with cortical tissue from this man. Many workers, particularly in the United States, believed, in his opinion incorrectly, that all the variants of Creutzfeldt-Jakob disease had a similar etiology. It was clear, however, from the paper by Roos et al. (Roos R, Gajdusek D C & Gibbs C J 1973 Brain 96, 1-20) that only the Nevin-Jones variant had been transmitted (Nevin S, McMenemey W H, Behrman S & Jones D P 1960 Brain 83, 519-563). This variant was characterized by a rapid deterioration, pronounced myoclonus, a typical EEG appearance at some time in the course of the disease, absence of lower motor neurone involvement and marked spongiform change at post-mortem. Two cases by Roos et al. (1973) were said to have had lower motor neurone involvement but the evidence was unconvincing. In one case fasciculation in the left gastrocnemius was cited as evidence and in the other there was said to be pronounced fasciculation clinically but the anterior horn cells were normal at post-mortem. If the present patient's disease could be transmitted this would be very good evidence of Creutzfeldt-Jakob disease being a single entity, as he showed unequivocal evidence of anterior horn cell disease. Why not send some material to Gajdusek? Alcoholic Dementia W J W Mallinson MRCP1 (for B I Hoffbrand MRCP) (Whittington Hospital, London N19) Mrs V W, aged 53 History: Admitted to hospital in August 1973. A story of increasing confusion and unsteadiness over the preceding six weeks was obtained from a friend; the events immediately preceding her admission have never been clarified. Subsequently a story was obtained of longstanding heavy alcohol consumption (mainly beer). 'Present address: St Bartholomew's Hospital, London ECI On examination: Wasted; extensive bruising of the limbs; clinically dehydrated; temperature 36°C. Pulse and blood pressure were unrecordable. Scattered rhonchi were heard in the chest. Liver enlarged by 5 cm; no signs of hepatocellular failure. Comatoseresponding slightly to painful stimuli. Fundi were normal. No signs of meningism. The limbs were flaccid and areflexic with flexor plantar responses.
Investigations: Hb 9.2 g/100 ml; MCV 110 , um3;  film showed macrocytosis; platelet count normal. ESR 48 mm in one hour (Westergren). Prothrombin ratio 1.1:1. Serum B12 340 pg/ml. Serum folate 3.2 ng/ml. Plasma urea 105 mg/ 100 ml, electrolytes normal. Blood sugar normal. Wassermann reaction negative. CSF (traumatic tap): WBC 5/mm3, RBC 405/mm3, protein 48, sugar 92 mg/100 ml. Skull X-rays normal. EEG showed a mild generalized abnormality suggesting diffuse cerebral disturbance. Progress: The patient improved initially with intravenous fluids; nystagmus and paresis of lateral eye movements then became apparent. A diagnosis of Wernicke's encephalopathy was made on the basis of these signs, and treatment with parenteral thiamine commenced. She rapidly regained consciousness and eye signs also improved. Subsequently she was grossly ataxic with persistently absent reflexes; the ataxia has improved so that she can now walk and feed herself. She remains disorientated, and there is marked loss of recent memory. The anemia has responded to treatment with folic acid.
Comment
This patient exhibits the classical features of the Wernicke-Korsakoff syndrome and has responded to thiamine treatment in the expected manner. She is left with severe intellectual damage; improvement in this respect, if it occurs, is likely to commence in the period from three months to two years after the onset of the illness (Victor etal. 1971) .
Thiamine deficiency has been established as the most important factor in the genesis of the Wernicke-Korsakoff syndrome, both by clinical observations of the response to treatment (Phillips et al. 1952) , and by animal experimentation. Cases have, however, been described with normal blood thiamine and transketolase levels only responding to multivitamin preparations and good diet (Cole et al. 1969) .
The clinical and pathological changes associated with other syndromes of alcoholic neurological disease (peripheral neuropathy, amblyopia, cerebellar degeneration, central pontine myelinolysis and Marchiafava-Bignami disease) have been described in non-alcoholics with a background of malnutrition. It therefore seems likely that they Clinical Section with Section ofPsychiatry 1065 arise through nutritional deficiency and not through any direct toxic effect of ethanol alone. A further uncommon pathological change found in demented alcoholics has been described by Morel (1939) as 'sclerose corticale laminaire ,alcoolique' but remains unclassified in this respect.
Alcoholic dementia should therefore be thought of as dementia due to alcoholism as opposed to dementia due to alcohol. C C, woman, born 11. 11.46 History: Aged 6 the patient suffered from 'chickenpox encephalitis'. During childhood she was accident prone. Apart from this she was healthy until the onset of symptoms at 22. No significant medical or psychiatric history in her family. Her initial complaint was of menorrhagia associated with a change, in her menstrual cycle from 28 to 14 days. Following this she started to experience feelings of panic on going out, together with increasing generalized anxiety, depression and insomnia. Despite an excellent work record over the previous five years she soon became unable to work and was admitted to a psychiatric hospital six months after the onset of symptoms. She was treated with a wide range of antidepressants and tranquillizers; modified ECT and ether abreactions failed to help her, and she remained in hospital for nearly three years.
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The first attack of stiffness occurred two years after the onset of symptoms. In a typical attack she lay rigid, unable to move, with her neck in opisthotonos, back arched in extension, abdomen board-like and lower limbs fixed in extension, feet plantar flexed. Her pupils were widely dilated, responding only sluggishly to light and her pulse rose to 180/minute. Tendon reflexes were symmetrically increased and bilateral knee clonus was present. Plantar responses were flexor and both Trousseau and Chovstek reactions were negative. Noise, active or passive movements of limbs, emotional upsets or even swallowing precipitated severe painful spasms, which caused dislocation of the right humerus on three occasions. These symptoms persisted for several days but disappeared during sleep and under general anmsthesia. Oral diazepam in massive doses (20 mg 4 times daily) produced complete control of physical symptoms within three days, the improvement starting 30 minutes after the first dose. Double blind substitution of placebo rapidly led to return of symptoms. Barbiturates and to a lesser extent phenothiazines were also effective in reducing stiffness, but mephenesin (up to 1.5 g 4 times daily) and baclofen (15 mg 4 times daily) were without significant effect. To maintain control of the physical symptoms, the daily dose of diazepam has had to be increased to 180 mg. Despite this high dose her conscious level is unimpaired. Though able to leave hospital she remains anxious and depressed, with a moderate fear of going out alone. The menstrual abnormality persists and insomnia is still a severe problem. Investigations: Hb 14.1 g/100 ml. WBC 7600/ mm3. ESR 8 mm in 1 hour (Westergren). Urea 17, sodium 143, potassium 4.2, chloride 103, calcium 10, P04 3.2, blood sugar 84 mg/100 ml (all during an attack of stiffness). Fasting plasma insulin 54 ,uu/ml (Searle immunoassay normal less than 25 psu/ml). Simultaneous blood sugar 82 mg/100 ml. Glucose tolerance test normal. EEG normal. EMG: 'continuous motor unit activity to a similar degree in both left triceps and left biceps. Attempts at active or passive movements produced generalized muscle spasm'. Urine: no reducing substances.
Discussion
Moersch & Woltman (1956) described a condition characterized by extraordinary muscle stiffness which they called 'stiff man syndrome '. Gordon et al. (1967) surveyed the world literature and established the definitive criteria which distinguish this unique syndrome from other causes of muscle stiffness. Most workers believe that the lesion lies at spinal cord level, either in the inhibitory internuncial neurones (Renshaw loop) 
